We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wall Street Loves Quantinuum Stock: Is it a Buy on the Post-IPO Rally?
Read MoreHide Full Article
Key Takeaways
Quantinuum has gained 45% since its June IPO, outperforming the industry and key quantum peers.
QNT drew broad Buy support from analysts after the IPO quiet period, with targets reaching $155.
Quantinuum could benefit from U.S. quantum funding, but commercialization and competition remain risks.
Quantinuum's (QNT - Free Report) June IPO marked a milestone for the quantum computing industry, becoming the largest U.S. IPO by a pure-play quantum company. The Honeywell (HON - Free Report) -backed company priced 28 million shares at $60 each, raising $1.68 billion, above its original target, reflecting robust institutional demand despite a volatile macro backdrop.
The stock has rewarded early investors. QNT began trading on Nasdaq on June 5, 2026. Since that debut, shares have rallied 45.2%, outperforming the Internet Software industry, which has fallen 3.7% during the same period. QNT has also comfortably outpaced leading publicly traded quantum peers, including IonQ (IONQ - Free Report) , D-Wave Quantum (QBTS - Free Report) and Rigetti Computing (RGTI - Free Report) , as the chart below shows.
Image Source: Zacks Investment Research
Wall Street Turns Increasingly Bullish on Quantinuum
Wall Street sentiment has turned overwhelmingly positive on Quantinuum following the expiration of the IPO quiet period. Multiple brokerages initiated coverage on June 29, with a vast majority assigning a Strong Buy or a Buy recommendation.
Among firms providing price targets, Rosenblatt Securities established the Street-high target of $155, implying nearly 90% upside from recent levels. Needham set a $100 target, while Evercore ISI assigned $98. Mizuho Securities, Jefferies and Cantor Fitzgerald each initiated with $90 price targets. Several other firms, including UBS, Bernstein, Craig-Hallum and Cowen, began coverage with Strong Buy ratings, although they did not disclose price targets.
Image Source: Zacks Investment Research
Quantinuum currently carries a Strong Buy consensus recommendation (average brokerage recommendation or ABR of 1.33), with eight of nine analysts recommending either Strong Buy or Buy. This suggests broad confidence in the company's long-term growth trajectory.
Government Backing Strengthens the Long-Term Growth Story
The supportive policy backdrop further strengthens the long-term investment case. The Trump administration recently announced a $2 billion initiative to accelerate U.S. quantum computing development, under which Quantinuum is slated to receive $100 million under the program. Combined with rising enterprise AI adoption and growing government demand for quantum technologies across defense and cybersecurity, these investments could accelerate commercialization over the coming decade.
Key Risks Remain Despite the Bullish Outlook
Investors should, however, remain mindful of the risks. Quantum computing remains an emerging industry with limited commercial revenues, elevated research and development spending and commercialization timelines that may extend well beyond this decade. Higher-for-longer interest rates also continue to put pressure on valuations of long-duration growth companies, while competition from IonQ, QBTS, IBM, Alphabet and Rigetti remains intense.
Final Verdict
Investors should monitor enterprise customer wins, commercialization of the Helios platform, progress toward the Apollo roadmap, expansion of government-funded quantum initiatives and growing contributions from higher-margin software and services. While QNT has surged more than 45% since its IPO, the company's long-term growth story depends heavily on its technological roadmap, timing and favorable policy tailwinds. With the stock now carrying a Zacks Rank #3 (Hold), prospective investors may benefit from waiting for a more attractive entry point or improved earnings visibility before accumulating shares.
Image: Bigstock
Wall Street Loves Quantinuum Stock: Is it a Buy on the Post-IPO Rally?
Key Takeaways
Quantinuum's (QNT - Free Report) June IPO marked a milestone for the quantum computing industry, becoming the largest U.S. IPO by a pure-play quantum company. The Honeywell (HON - Free Report) -backed company priced 28 million shares at $60 each, raising $1.68 billion, above its original target, reflecting robust institutional demand despite a volatile macro backdrop.
The stock has rewarded early investors. QNT began trading on Nasdaq on June 5, 2026. Since that debut, shares have rallied 45.2%, outperforming the Internet Software industry, which has fallen 3.7% during the same period. QNT has also comfortably outpaced leading publicly traded quantum peers, including IonQ (IONQ - Free Report) , D-Wave Quantum (QBTS - Free Report) and Rigetti Computing (RGTI - Free Report) , as the chart below shows.
Image Source: Zacks Investment Research
Wall Street Turns Increasingly Bullish on Quantinuum
Wall Street sentiment has turned overwhelmingly positive on Quantinuum following the expiration of the IPO quiet period. Multiple brokerages initiated coverage on June 29, with a vast majority assigning a Strong Buy or a Buy recommendation.
Among firms providing price targets, Rosenblatt Securities established the Street-high target of $155, implying nearly 90% upside from recent levels. Needham set a $100 target, while Evercore ISI assigned $98. Mizuho Securities, Jefferies and Cantor Fitzgerald each initiated with $90 price targets. Several other firms, including UBS, Bernstein, Craig-Hallum and Cowen, began coverage with Strong Buy ratings, although they did not disclose price targets.
Image Source: Zacks Investment Research
Quantinuum currently carries a Strong Buy consensus recommendation (average brokerage recommendation or ABR of 1.33), with eight of nine analysts recommending either Strong Buy or Buy. This suggests broad confidence in the company's long-term growth trajectory.
Government Backing Strengthens the Long-Term Growth Story
The supportive policy backdrop further strengthens the long-term investment case. The Trump administration recently announced a $2 billion initiative to accelerate U.S. quantum computing development, under which Quantinuum is slated to receive $100 million under the program. Combined with rising enterprise AI adoption and growing government demand for quantum technologies across defense and cybersecurity, these investments could accelerate commercialization over the coming decade.
Key Risks Remain Despite the Bullish Outlook
Investors should, however, remain mindful of the risks. Quantum computing remains an emerging industry with limited commercial revenues, elevated research and development spending and commercialization timelines that may extend well beyond this decade. Higher-for-longer interest rates also continue to put pressure on valuations of long-duration growth companies, while competition from IonQ, QBTS, IBM, Alphabet and Rigetti remains intense.
Final Verdict
Investors should monitor enterprise customer wins, commercialization of the Helios platform, progress toward the Apollo roadmap, expansion of government-funded quantum initiatives and growing contributions from higher-margin software and services. While QNT has surged more than 45% since its IPO, the company's long-term growth story depends heavily on its technological roadmap, timing and favorable policy tailwinds. With the stock now carrying a Zacks Rank #3 (Hold), prospective investors may benefit from waiting for a more attractive entry point or improved earnings visibility before accumulating shares.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.